BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND WHSC1, 7468, O96028, WHS, TRX5, REIIBP, NSD2, MMSET, MGC176638, KIAA1090, FLJ23286
26 results:

  • 1. Circ-FOXO3 inhibits triple-negative breast cancer growth and metastasis via regulating whsc1-H3K36me2-Zeb2 axis.
    Chen D; Zeng S; Qiu H; Yang M; Lin X; Lv X; Li P; Weng S; Kou S; Luo K; Liu Z; Yi Y; Liu H
    Cell Signal; 2024 May; 117():111079. PubMed ID: 38341124
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Accelerometer-measured physical activity and postmenopausal breast cancer incidence in the Women's Health Accelerometry Collaboration.
    Hyde ET; LaCroix AZ; Evenson KR; Howard AG; Anuskiewicz B; Di C; Bellettiere J; LaMonte MJ; Manson JE; Buring JE; Shiroma EJ; Lee IM; Parada H
    Cancer; 2023 May; 129(10):1579-1590. PubMed ID: 36812131
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparative Genomic Profiling of Second breast cancers following First Ipsilateral Hormone Receptor-Positive breast cancers.
    Rassy E; Garberis I; Tran-Dien A; Job B; Chung-Scott V; Bouakka I; Bassil J; Ferkh R; Lacroix-Triki M; Zanconati F; Giudici F; Generali D; Rouleau E; Lacroix L; Andre F; Pistilli B
    Clin Cancer Res; 2023 May; 29(9):1822-1831. PubMed ID: 36805183
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testing.
    Llorin H; Graf M; Chun N; Ford J
    Cancer Genet; 2022 Nov; 268-269():22-27. PubMed ID: 36116289
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Activating transcription factor 2 promotes the progression of hepatocellular carcinoma by inducing the activation of the whsc1-mediated TOP2A/PI3K/AKT axis.
    Bao ZM; Yao D; Qian X; Zhang HG; Yang M; Guo YH; Qin L
    Kaohsiung J Med Sci; 2022 Jul; 38(7):662-674. PubMed ID: 35394699
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Branched-Chain Amino Acids and Risk of breast cancer.
    Zeleznik OA; Balasubramanian R; Ren Y; Tobias DK; Rosner BA; Peng C; Bever AM; Frueh L; Jeanfavre S; Avila-Pacheco J; Clish CB; Mora S; Hu FB; Eliassen AH
    JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34585062
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. nsd2 promotes tumor angiogenesis through methylating and activating STAT3 protein.
    Song D; Lan J; Chen Y; Liu A; Wu Q; Zhao C; Feng Y; Wang J; Luo X; Cao Z; Cao X; Hu J; Wang G
    Oncogene; 2021 Apr; 40(16):2952-2967. PubMed ID: 33742125
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Association of Overall Annual Hospital Volume and Perioperative Outcomes following Free Flap breast Reconstruction.
    Shammas RL; Ren Y; Thomas SM; Phillips BT; Hollenbeck ST; Greenup RA
    Plast Reconstr Surg; 2021 Feb; 147(2):196e-206e. PubMed ID: 33565821
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. whsc1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
    Zhang J; Lu J; Chen Y; Li H; Lin L
    J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
    [No Abstract]    [Full Text] [Related]  

  • 10. EZH2 and mmset Were Identified as Potentially Useful Therapeutic Targets in Metaplastic breast Carcinoma.
    Nakayama H; Kawachi K; Suganuma N; Yoshida T; Yamashita T; Yamanaka T; Matsubara Y; Kohagura K; Toda S; Nakamura Y; Miyagi Y; Rino Y; Masuda M
    Anticancer Res; 2020 Apr; 40(4):2133-2139. PubMed ID: 32234906
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of nsd2 degradation and suppression of nsd2-driven redox homeostasis.
    Wang Q; Zheng J; Zou JX; Xu J; Han F; Xiang S; Liu P; Chen HW; Wang J
    Chem Biol Interact; 2020 Feb; 317():108965. PubMed ID: 32001260
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Histone methyltransferase nsd2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling.
    Wang JJ; Zou JX; Wang H; Duan ZJ; Wang HB; Chen P; Liu PQ; Xu JZ; Chen HW
    Acta Pharmacol Sin; 2019 Aug; 40(8):1067-1075. PubMed ID: 30670815
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Reprogramming metabolism by histone methyltransferase nsd2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes.
    Wang J; Duan Z; Nugent Z; Zou JX; Borowsky AD; Zhang Y; Tepper CG; Li JJ; Fiehn O; Xu J; Kung HJ; Murphy LC; Chen HW
    Cancer Lett; 2016 Aug; 378(2):69-79. PubMed ID: 27164560
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment.
    Gu C; Feng L; Peng H; Yang H; Feng Z; Yang Y
    Oncotarget; 2016 Jan; 7(4):4559-69. PubMed ID: 26683226
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.
    Katoh M
    Epigenomics; 2016 Feb; 8(2):285-305. PubMed ID: 26411517
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Plasma C-reactive protein and risk of breast cancer in two prospective studies and a meta-analysis.
    Wang J; Lee IM; Tworoger SS; Buring JE; Ridker PM; Rosner B; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1199-206. PubMed ID: 25994740
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An epigenomic approach to therapy for tamoxifen-resistant breast cancer.
    Feng Q; Zhang Z; Shea MJ; Creighton CJ; Coarfa C; Hilsenbeck SG; Lanz R; He B; Wang L; Fu X; Nardone A; Song Y; Bradner J; Mitsiades N; Mitsiades CS; Osborne CK; Schiff R; O'Malley BW
    Cell Res; 2014 Jul; 24(7):809-19. PubMed ID: 24874954
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Differential effect of mmset mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer.
    Wei J; Costa C; Shen J; Yu L; Sanchez JJ; Qian X; Sun X; Zou Z; Gimenez-Capitan A; Yue G; Guan W; Rosell R; Liu B
    Br J Cancer; 2014 May; 110(11):2662-8. PubMed ID: 24809779
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Does MRI breast "density" (degree of background enhancement) correlate with mammographic breast density?
    Hansen NL; Kuhl CK; Barabasch A; Strobel K; Schrading S
    J Magn Reson Imaging; 2014 Aug; 40(2):483-9. PubMed ID: 24446230
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.